The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource. Please follow the citation guidelines if you are using it.
×
TSP1293-CMap - NLT_B: Toxicogenomic signatures after exposure to tamoxifen TSA9811-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen TSA9821-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen TSF13853-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.39 µM 1 subfactor(s) TSF13854-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.2 µM 1 subfactor(s) TSF13847-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 24.98 µM 1 subfactor(s) TSF13848-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 12.46 µM 1 subfactor(s) TSF13849-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 6.24 µM 1 subfactor(s) TSF13850-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 3.12 µM 1 subfactor(s) TSF13855-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.1 µM 1 subfactor(s) TSF13851-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 1.6 µM 1 subfactor(s) TSF13852-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.8 µM 1 subfactor(s) TSF13856-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.05 µM 1 subfactor(s) TSF13923-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 49.99 µM 1 subfactor(s) TSF13957-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 24.98 µM 1 subfactor(s) TSF13963-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.39 µM 1 subfactor(s) TSF13958-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 12.46 µM 1 subfactor(s) TSF13959-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 6.24 µM 1 subfactor(s) TSF13960-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 3.12 µM 1 subfactor(s) TSF13961-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 1.6 µM 1 subfactor(s) TSF13962-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.8 µM 1 subfactor(s) TSF13964-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.2 µM 1 subfactor(s) TSF13965-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.1 µM 1 subfactor(s) TSF13966-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.05 µM 1 subfactor(s) TSS13856-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.39 µM TSS13857-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.2 µM TSS13850-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 24.98 µM TSS13851-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 12.46 µM TSS13852-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 6.24 µM TSS13853-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 3.12 µM TSS13858-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.1 µM TSS13854-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 1.6 µM TSS13855-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.8 µM TSS13859-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 0.05 µM TSS13926-CMap - NLT_B: Toxicogenomic signatures in the human cell line A549 after exposure to tamoxifen 49.99 µM TSS13960-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 24.98 µM TSS13966-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.39 µM TSS13961-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 12.46 µM TSS13962-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 6.24 µM TSS13963-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 3.12 µM TSS13964-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 1.6 µM TSS13965-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.8 µM TSS13967-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.2 µM TSS13968-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.1 µM TSS13969-CMap - NLT_B: Toxicogenomic signatures in the human cell line MCF7 after exposure to tamoxifen 0.05 µM
TSP1293 - CMap - NLT_B: Toxicogenomic signatures after exposure to tamoxifen
Public
https://clue.io/data/NLT#NLT_B
Experimental design
No experimental design provided
Results
No results provided